Abstract
The proliferative status of a cell population and its kinetics of proliferation recovery following treatment with antitumor agents are important determinants in the final outcome of the drug-cell interaction. Antitumor agents generate two types of unrelated effects in treated cells: cell kill and delayed transit through the mitotic cycle (Drewinko and Barlogie 1976 b; Madoc-Jones and Mauro 1975). Therefore, cell proliferation may be decreased because of actual cell kill or because of perturbation of the normal rate of progression through the cycle. This perturbation may be manifested in various forms including cycle stage traverse delay, a reversible or irreversible block in a particular stage of the cycle, or, more commonly, a combination of these factors. This temporary lag in the multiplication rate may increase the doubling time of the treated population and produce results indistinguishable from those obtained in populations whose cells are actually killed (Roper and Drewinko 1976). In addition, the reassortment and new distribution in different proliferative compartments or stages of the cell cycle experienced by the population will influence profoundly the effect of the same or another agent administered at subsequent intervals, thus resulting in either increased or decreased sensitivity to the agent (Dethlefsen 1975, 1979).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alabaster O, Tannenbaum E, Habersett MC, Magrath I, Herman C (1978) Drug-induced changes in DNA fluorescence intensity detected by flow microfluorometry and their implications for analysis of DNA content distributions. Cancer Res 38:1031–1035
Barlogie B, Drewinko B (1976) Cell cycle-related induction of cell progression delay. In: Drewinko B, Humphrey RM (eds) Growth kinetics and biochemical regulation of normal and malignant cells. Williams and Wilkins, Baltimore, p 315
Barlogie B, Drewinko B (1978) Cell cycle stage-dependent induction of G2 phase arrest by different antitumor agents. Eur J Cancer 14:741–745
Barlogie B, Drewinko B (1980) Lethal and cytokinetic effects of mitomycin C on cultured human colon cancer cells. Cancer Res 40:1973–1980
Barlogie B, Drewinko B, Johnston DA, Buchner T, Hauss WH, Freireich EJ (1976 a) Pulse cytophotometric analysis of synchronized cells in vitro. Cancer Res 36:1176–1181
Barlogie B, Drewinko B, Johnston DA, Freireich EJ (1976 b) The effects of adriamycin on the cell cycle traverse of a human lymphoid cell line. Cancer Res 36:1975
Barlogie B, Corry P, Drewinko B (1980) In vitro thermochemotherapy of human colon cancer cells with cisplatinum and mitomycin C. Cancer Res 40:1165–1168
Barranco SC, Humphrey RM (1971) The effects of β-2’-deoxythioguanosine on survival and progression in mammalian cells. Cancer Res 31:583–586
Barranco SC, Novak JK (1974) Survival response of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine or adriamycin. Cancer Res 34:1616–1618
Barranco SC, Novak JK, Humphrey RM (1973) Response of mammalian cells following treatment with bleomycin and l,3-bis(2-chloroethyl)-l-nitrosourea during plateau phase. Cancer Res 33:691–694
Barranco SC, Bolton WE, Novak JK (1979) A simple method for producing different growth fractions in vitro for use in anticancer drug studies. Cell Tissue Kinet 12:11–16
Ben-Ishay Z, Farber E (1975) Protective effects of an inhibitor of protein synthesis, cycloheximide on bone marrow damage induced by cytosine arabinoside or nitrogen mustard. Lab Invest 33:478–490
Bergerat J-P, Barlogie B, Gohde W, Johnston DA, Drewinko B (1979) In vitro cytokinetic response of human colon cancer cells to cw-dichlorodiammine-platinum (II). Cancer Res 39:4356–4363
Bhuyan BJ, Scheldt LG, Fraser TJ (1972) Cell cycle phase specificity of antitumor agents. Cancer Res 32:398–407
Bhuyan BK, Loughman BE, Fraser TJ, Day KJ (1976) Comparison of different methods of determining cell viability after exposure to cytotoxic compounds. Exp Cell Res 97:275–280
Bhuyan BK, Fraser TJ, Day KJ (1977) Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured LI210 cells. Cancer Res 37:1057–1063
Blackett NM, Adams K (1972) Cell proliferation and action of cytotoxic agents on haemo-poietic tissue. Br J Haematol 23:751–758
Borsa J, Whitmore GF (1969) Cell killing studies on the mode of action of methotrexate on L-cells in vitro. Cancer Res 29:737–744
Brachetti S, Whitmore GF (1969) The action of hydroxyurea in mouse L-cells. Cell Tissue Kinet 2:193
Bradley MO, Kohn KW, Sharkey NA, Ewig RA (1977) Differential cytotoxicity between transformed and normal human cells with combinations of aminonucleosides and hydroxyurea. Cancer Res 37:2126–2131
Bruce WR, Meeker BE, Valeriote FA (1966) Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst 37:233–245
Capizzi RL (1974) Biochemical interaction between asparaginase (AASE) and methotrexate (MTX) in leukemia cells. Proc Am Assoc Cancer Res 15:77
Capizzi RL, Summers WP, Bertino JR (1971) L-asparaginase-induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y. Ann NY Acad Sci 186:302–311
Clarkson BD (1974) The survival value of the dormant state in neoplastic and normal cell populations. In: Clarkson B, Baserga R (eds) Control of proliferation in animal cells. Cold Spring Harbor, New York, p 945
Dethlefsen LA (1979) Cellular recovery kinetic studies relevant to combined-modality research and therapy. Int J Radiat Oncol Biol Phys 5:1197–1203
Dethlefsen LA, Riley RM (1973 a) Hydroxyurea effects in the C3H mouse. I. Duodenal crypt cell kinetics. Cell Tissue Kinet 6:3–16
Dethlefsen LA, Riley RM (1973 b) Hydroxyurea effects in the C3H mouse. II. Mammary tumor cell kinetics. Cell Tissue Kinet 6:173–184
Dethlefsen LA, Sorensen SP, Riley RM (1975) Effects of double and multiple doses of hydroxyurea on mouse duodenum and mammary tumors. Cancer Res 35:694–699
Dethlefsen LA, Ohlsen JD, Roti Roti JL (1977) Cell synchronization in vivo: fact or fancy? In: Drewinko B, Humphrey RM (eds) Growth kinetics and biochemical regulation of normal and malignant cells. Williams and Wilkins, Baltimore, pp 491–507
Dethlefsen LA, Riley RM, Roti Roti (1979) Flow cytometric analysis of adriamycin-perturbated mouse mammary tumor. J Histochem Cytochem 27:463–469
Dosik GM, Barlogie B, Johnston DA, Murphy WK, Drewinko B (1978) Lethal and cytokinetic effects of anguidine on a human colon cancer cell line. Cancer Res 38:3304–3309
Dosik GM, Barlogie B, White A, Gohde W, Drewinko B (1981) A rapid automated stath-mokinetic method for determination of in vitro cell cycle transit times. Cell Tissue Kinet 14:121–134
Drewinko B, Barlogie B (1976 a) Survival and cycle progression delay of human lymphoma cells in vitro exposed to 4’demethylepipodophyllotoxin 9-(4,6-0-ethylidine-β-D-glucopyranoside) (NSC 141540; VP016). Cancer Treat Rep 60:1295
Drewinko B, Barlogie B (1976 b) Age-dependent survival and cell-cycle progression of cultured cells exposed to chemotherapeutic agents. Cancer Treat Rep 60:1707
Drewinko B, Ho DHN, Barranco SC (1972) The effects of arabinosylcytosine on cultured human lymphoma cells. Cancer Res 32:2737–2742
Drewinko B, Lichtiger B, Trujillo JM (1973) Synchronization of cultured human lymphoid cells. Biomedicine 18:30–37
Drewinko B, Romsdahl MM, Yang L-Y, Ahearn MJ, Trujillo JM (1976) Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res 36:467–475
Drewinko B, Bobo B, Roper P, Malahy MA, Barlogie B, Jansson B (1978 a) Analysis of the growth kinetics of a human lymphoma cell line. Cell Tissue Kinet 11:177–191
Drewinko B, Yang L-Y, Barlogie B, Romsdahl M, Meistrich M, Malahy MA; Giovanella B (1978 b) Further biological characteristics of an established human carcino-em-bryonic antigen producing colon carcinoma cell line. J Natl Cancer Inst 61:75–83
Drewinko B, Barlogie B, Freireich EJ (1979 a) Response of exponentially growing, stationary phase and synchronized cultured colon carcinoma cells to treatment with nitrosourea derivatives. Cancer Res 39:3630–3636
Drewinko B, Roper PR, Barlogie B (1979 b) Patterns of cell survival following treatment with antitumor agents in vitro. Eur J Cancer 15:95–99
Drewinko B, Barlogie B, Mars W, Malahy MA, Jansson B (1979 c) Proliferative characteristics of ARH-77 cells, an established human IgG-producing myeloma cell line. Cell Tissue Kinet 12:675
Drewinko B, Alexanian R, Boyer H, Barlogie B, Rubinow S (1981 a) The growth fraction of human myeloma cells. Blood 57:333–338
Drewinko B, Patchen M, Yang L-Y, Barlogie B (1981b) Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells. Cancer Res 4:2328–2333
Dubrow R, Riddle VGH, Pardee AB (1979) Different responses to drugs and serum of cells transformed by various means. Cancer Res 39:2718–2726
Edelstein M, Vietti T, Valeriote F (1974) Schedule dependent synergism for the combination of l-β-D-arabinofuranosyl cytosine and daunorubicin. Cancer Res 34:293–297
Edelstein M, Vietti T, Valeriote F (1975) The enhanced cytotoxicity of combinations of 1-ß-D-arabinoguranosylcytosine and methotrexate. Cancer Res 35:1555–1558
Ehmann UK, Wheeler KT (1979) Cinemicrographic determination of cell progression and division abnormalities after treatment with 1,3 bis(2-chloroethyl)-l-nitrosourea (BCNU). Eur J Cancer 15:461–474
Epifanova OI (1977) Mechanisms underlying the differential sensitivity of proliferating and resting cells to external factors. Int Rev Cytol [Suppl] 5:303–335
Epifanova OI, Smolenskaya IN, Polunovsky VA (1978) Responses of proliferating and nonproliferating Chinese hamster cells to cytotoxic agents. Br J Cancer 37:377–385
Ford SS, Shackney SE (1977) Lethal and sublethal effects of hydroxyurea in relation to drug concentration and duration of drug exposure in sarcoma 180 in vitro. Cancer Res 37:2628–2637
Fried J (1976) Method for the quantitative evaluation of data from flow microfluorometry. Computers Biomed Res 9:277–290
Galavazi G, Schenk H, Bootsma I (1966) Synchronization of mammalian cells in vitro by inhibition of the DNA synthesis. I. Optimal conditions. Exp Cell Res 41:428–433
Ganapathi R, Krishan A (1978) Cell cycle synchronization of L1210 and P388 ascites in vivo. Cell Tissue Kinet 11:681
Gelfant S (1977) A new concept of tissue and tumor cell proliferation. Cancer Res 37:3845–3862
Glinos AD, Werrlem RJ (1972) Density dependent regulation of growth on suspension cultures of L-929 cells. J Cell Physiol 79:79–90
Greenberg PL, Mosny SA (1977) Cytotoxic effects of interferon in vitro on granulocytic progenitor cells. Cancer Res 3:1794–1799
Hagemann RF, Schenken LL, Lesher S (1973) Tumor chemotherapy efficacy dependent on mode of growth. J Natl Cancer Inst 50:467–474
Hahn GM, Little LB (1972) Plateau-phase cultures of mammalian cells. An in vitro model for human cancer. Curr Top Radiat Res 8:39–83
Hahn GM, Ray GR, Gordon, DE, Kallman RF (1973) Response of solid tumor cells exposed to chemotherapeutic agents in vitro. Cell curvival after 2-and 24-hour exposure. J Natl Cancer Inst 50:529–533
Hill BT, Whelan RDH (1981) Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines. J Natl Cancer Inst
Johnston DA, White RA, Barlogie B (1978) Automatic processing and interpretation of DNA distributions: comparison of several techniques. Comput Biomed Res 11:393–404
Kaneko T, LePage GA (1978) Growth characteristics and drug responses of a murine lung carcinoma in vitro and in vivo. Cancer Res 38:2084–2090
Kim LH, Perez AG, Djordjevic B (1968) Studies on unbalanced growth in synchronized HeLa cells. Cancer Res 28:2443–2447
Kouns A (1975) Differential effects of isoleucine deprivation on cell motility, membrane transport and DNA synthesis in N1L8 hamster cells. Exp Cell Res 94:15–22
Lahiri SK (1973) Response of mouse bone marrow colony-forming units in different stages of the cell cycle to in vitro incubation with mitomycin C. Cell Tissue Kinet 6:509–514
Lambert WC, Studzinsky G (1967) Recovery from prolonged unbalanced growth induced in HeLa cells by high concentration of thymidine. Cancer Res 27:2364–2370
Lieberman MW, Verbin RS, Landay MM, Liang H, Farber E, Lee TN, Starr R (1970) A probable role for protein synthesis in intestinal epithelial cell damage induced in vivo by cytosine arabinoside, nitrogen mustard or x-irradiation. Cancer Res 30:942–4951
Macieira-Coelho A (1967) Influence of cell density on growth inhibition of human fibroblasts in vitro. Proc Soc Exp Biol Med 125:548–552
Madoc-Jones, Bruce WR (1967) Sensitivity of L-cells in exponential and stationary phase to 5-fluorouracil. Nature 215:302–303
Madoc-Jones H, Mauro F (1969) Interphase action of vinblastine and vincristine: differences in their lethal action through the mitotic cycle of cultured mammalian cells. J Cell Physiol 72:185–196
Madoc-Jones H, Mauro F (1970) Age responses to x-rays, Vinca alkaloids and hydroxyurea of murine lymphoma cells synchronized in vivo. J Natl Cancer Inst 45:1131–1143
Madoc-Jones H, Mauro F (1975) Site of action of cytotoxic agents in the cell life cycle. In: Sartorelli A, Johns D (eds) Antineoplastic and immunosuppressive agents. Springer, Berlin Heidelberg New York, p 205 (Handbook of Experimental Pharmacology, vol 38)
Mauro F, Falpo B, Briganti G, Elli R, Zupi G (1974 a) Effects of antineoplastic drugs on plateau-phase cultures of mammalian cells. I. Description of the plateau-phase system. J Natl Cancer Inst 52:705–713
Mauro F, Falpo B, Briganti G, Elli R, Zupi G (1974 b) Effects of antineoplastic drugs on plateau-phase cultures of mammalian cells. II. Bleomycin and hydroxyurea. J Natl Cancer Inst 52:715–722
Melamed MR, Mullaney PF, Mendelsohn ML (1979) Flow cytometry and sorting. Wiley, New York
Olah E, Palyi I, Sugar J (1978) Effects of cytostatics on proliferating and stationary cultures of mammalian cells. Eur J Cancer 14:895–900
Papirmeister B, Davidson CL (1965) Unbalanced growth and latent killing of Escherichia coli following exposure to sulfur mustard. Biochim Biophys Acta 103:70–92
Pardee AB (1974) A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 71:1286
Pardee AB, James LJ (1975) Selective killing of transformed baby hamster kidney (BHK) cells. Proc Natl Acad Sci USA 72:4994–4998
Peel S, Cowen DM (1972) The effect of cyclophosphamide on the growth and cellular kinetics of a transplantable rat fibrosarcoma. Br J Cancer 26:304–314
Pittillo RF, Schabel FM, Skipper HE (1970) The “sensitivity” of resting and dividing cells. Cancer Chemother Rep 54:137–142
Puck TT, Marcus PI (1955) A rapid method for viable cell titration and clone production with HeLa cells in tissue culture. Proc Natl Acad Sci USA 41:432–437
Rajewsky MF (1975) Proliferative parameters relevant to cancer therapy. In: Grundmann E, Gross R (eds) The ambivalence of cytostatic therapy. Springer, Berlin Heidelberg New York, pp 156–171 (Recent results in cancer research, vol 52)
Ray GR, Hahn GM, Bagshaw MA, Kurkjian S (1973) Cell survival and repair of plateauphase cultures after chemotherapy - relevance to tumor therapy and to the in vitro screening of new agents. Cancer Chemother Rep 57:473–475
Razek A, Vietti T, Valeriote F (1974) Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo. Cancer Res 34:1857–1861
Razek A, Valeriote F, Vietti T (1980) Effect of dose fractionation of daunorubicin on survival of leukemic cells. Cancer Res 40:2835–2838
Roberts JJ, Brent TP, Crathorn AR (1971) Evidence for the inactivation and repair of the mammalian DNA template after alkylation by mustard gas and half mustard gas. Eur J Cancer 7:515–524
Roper P, Drewinko B (1976) Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Res 36:2182–2188
Roper PR, Drewinko B (1979) Cell survival following treatment with antitumor drugs. Cancer Res 39:1428–1430
Rosenblum ML, Wheeler KT, Wilson CB, Barker M, Kuebel KD (1975) In vitro evaluation of in vivo brain tumor chemotherapy with l,3-bis(2-chloroethyl)-l-nitrosourea. Cancer Res 35:1387–1391
Ross DW, Sinclair WK (1972) Cell cycle compartment analysis of Chinese hamster cells in stationary phase cultures. Cell Tissue Kinet 5:1–14
Roti Roti JL, Dethlefsen LA (1975) Matrix simulation of duodenal crypt cell kinetics. II. Cell kinetics following hydroxyurea. Cell Tissue Kinet 8:335–353
Rozengurt E, Po CC (1976) Selective cytotoxicity for transformed 3T3 cells. Nature 261:701–702
Rupniak HT, Paul D (1980) Selective killing of transformed cells by exploitation of their defective cell cycle control by polyamines. Cancer Res 40:293–297
Schabel FM (1969) The use of tumor growth kinetics in planning “curative” chemotherapy of advanced solid tumors. Cancer Res 29:2384–2389
Shackney SE, Erickson BW, Lengel CE (1978) Schedule optimization of cytosine arabinoside (CA) and hydroxyurea (HU) in sarcoma 180 in vitro. Proc Am Assoc Cancer Res, Abstract 900
Skipper HE (1970) Leukocyte kinetics in leukemia and lymphoma. In: Clark RL (ed) Leukemia - Lymphoma. Year Book Medical Publishers, Chicago, p 27
Steel GG (1977) Growth kinetics of tumours. Clarendon, Oxford
Stragand JJ, Bergerat J-P, White RA, Hokanson J, Drewinko B (1980) Biological and cell kinetic characteristics of a human colonic adenocarcinoma (LoVo) growth in athymic mice. Cancer Res 40:2846–2852
Sutherland RM (1974) Selective chemotherapy of noncycling cells in an in vitro tumor model. Cancer Res 34:3501–3503
Teodori L, Barlogie B, Drewinko B, Swatzendruber D, Mauro F (1981) Reduction of ara- C and adriamycin cytotoxicity following cell cycle arrest by anguidine. Cancer Res 41:1263–1270
Thatcher CJ, Walker IG (1969) Sensitivity of confluent and cycling embryonic hamster cells to sulfur mustard, l,3-bis(2-chloroethyl)-l-nitrosourea and actinomycin D. J Natl Cancer Inst 42:363–368
Till JE, Whitmore GF, Gulyas S (1963) Deoxyribonucleic acid synthesis in individual L-strain mouse cells. II. Effects of thymidine starvation. Biochim Biophys Acta 72:277–281
Tobey RA, Ley KD (1970) Regulation of initiation of DNA synthesis in Chinese hamster cells. I. Production of stable, reversible, Gx-arrested population in suspension culture. J Cell Biol 46:151–157
Tobey RA, Peterson DF, Anderson ED, Puck TT (1966) Life cycle analysis of mammalian cells. II. The inhibition of division in Chinese hamster cells by puromycin and actinomycin. Biophys J 6:567–572
Tobey RA, Petersen DF, Anderson ED (1971) Biochemistry of G2 and mitosis. In: Baserga R (ed) The cell cycle and cancer, vol 1. Dekker, New York, p 309
Tubiana M, Guichard M, Malaise EP (1977) Determinants of cell kinetics in radiotherapy. In: Drewinko B, Humphrey RM (eds) Growth kinetics and biochemical regulation of normal and malignant cells. William and Wilkins, Baltimore, pp 827–842
Twentyman PR (1976) Comparative chemosensitivity of exponential-versus plateau-phase cells in both in vitro and in vivo model systems. Cancer Treat Rep 60:1719–1722
Twentyman PR, Bleehen NM (1973) The sensitivity of cells in exponential and stationary phases of growth to bleomycin and to l,3-bis(2-chloroethyl)-l-nitrosourea. Br J Cancer 28:500–507
Twentyman PR, Bleehen NM (1975) Changes in sensitivity to radiation and to bleomycin occurring during the life history of monolayer cultures of a mouse tumour cell line. Br J Cancer 31:68–74
Valeriote F, Hsui-san L (1975) Synergistic interaction of anticancer agents; a cellular perspective. Cancer Chemother Rep 59:895–900
Valeriote F, van Putten L (1975) Proliferation-dependent cytotoxicity of anti-cancer agents: a review. Cancer Res 35:2619–2630
Valeriote FA, Vietti D, Tolen S (1973) Kinetics of the lethal effects of actinomycin D on normal and leukemic cells. Cancer Res 33:2658–2661
van Putten LM (1974) Are cell kinetic data relevant for the design of tumour chemotherapy schedules? Cell Tissue Kinet 7:493–504
van Putten LM, Lelieveld P, Kram Idsenga LKJ (1972) Cell-cycle specificity and therapeutic effectiveness of cytostatic agents. Cancer Chemother Rep 56:691–700
Verbin RS, Diluiso G, Farber E (1973) Protective effects of cycloheximide against 1-/β-D-arabinosylcytosine-induced intestinal lesions. Cancer Res 33:2086–2093
Weissberg JB, Herion JC, Walker RI, Palmer JG (1978) Effect of cycloheximide on the bonemarrow toxicity of nitrogen mustard. Cancer Res 38:1523–1527
Wotring LL, Roti Roti JL (1980) Thioguanine-induced S and G2 blocks and their significance to the mechanism of cytotoxicity. Cancer Res 40:1458–1462
Zubrod GC (1969) Trends in chemotherapy research. Can Cancer Conf 8:31–39
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Drewinko, B., Barlogie, B. (1984). Cell Cycle Perturbation Effects. In: Fox, B.W., Fox, M. (eds) Antitumor Drug Resistance. Handbook of Experimental Pharmacology, vol 72. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69490-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-69490-5_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69492-9
Online ISBN: 978-3-642-69490-5
eBook Packages: Springer Book Archive